Devyser Diagnostics AB Capital Reinvestment Ratio
Devyser Diagnostics AB capital reinvestment ratio. Devyser Diagnostics AB (DVYSR) has a Capital Reinvestment Ratio of 1.17x as of June 2026, meaning it reinvests 1% of its operating cash flow (Skr12.30 Million) in capital expenditures (Skr14.40 Million). Check Devyser Diagnostics AB total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Devyser Diagnostics AB (2018–2025)
Capital reinvestment ratio of Devyser Diagnostics AB from 2018 to 2025. This chart tracks Devyser Diagnostics AB's Capital Reinvestment Ratio across 4 annual periods. Also explore Devyser Diagnostics AB net asset momentum to track the company's year-over-year net asset growth rate.
Devyser Diagnostics AB Capital Reinvestment Ratio by Year (2018–2025)
Devyser Diagnostics AB capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see DVYSR cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Skr8.20 Million | Skr1.50 Million | ▼ -96.6% |
| 2020 | 5.44x | Skr627.00K | Skr3.41 Million | ▲ +755.5% |
| 2019 | 0.64x | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr6.02 Million | Skr5.06 Million | — |